Showing results (401-410 of 883) with videos related to
Sort By:
Pageof 89
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 29, 2017
Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablationLuigi Di Biase, David Callans, Karl Georg Hæusler, et al.Journal of the American Heart Association|January 19, 2022
Hyperglycemia, Risk of Subsequent Stroke, and Efficacy of Dual Antiplatelet Therapy: A Post Hoc Analysis of the POINT TrialBrian Mac Grory, Jonathan P Piccini, Shadi Yaghi, et al.Journal of Cardiovascular Translational Research|May 28, 2020
Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19Marat Fudim, Yawar J Qadri, Kamrouz Ghadimi, et al.Heart Rhythm|November 8, 2024
Complications associated with pulsed field ablation vs radiofrequency catheter ablation of atrial fibrillationMin Soo Cho, So-Ryoung Lee, Eric Black-Maier, et al.Heart Rhythm O2|June 16, 2023
Racial/ethnic and sex differences in safety outcomes and atrial fibrillation/atrial flutter-related acute healthcare utilization after catheter ablation of atrial fibrillationLarry R Jackson, Daniel J Friedman, Diane M Francis, et al.Heart Rhythm|November 27, 2010
Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Jonathan P Piccini, Sana M Al-Khatib, Anne S Hellkamp, et al.American Heart Journal|March 8, 2017
Cardioversion and subsequent quality of life and natural history of atrial fibrillationSean D Pokorney, Sunghee Kim, Laine Thomas, et al.Journal of the American College of Cardiology|March 21, 2020
Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal DiseaseSean D Pokorney, Eric Black-Maier, Anne S Hellkamp, et al.Journal of the American Heart Association|May 6, 2016
Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) RegistryEmily C O'Brien, Sunghee Kim, Laine Thomas, et al.European Heart Journal|June 16, 2009
Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathyLaëtitia Duboscq-Bidot, Philippe Charron, Volker Ruppert, et al.Pageof 89